We study the pathogenesis of neuronal disorders
to develop therapeutics and biomarkers
for neurodegenerative and dementia diseases.

Our current interests include molecular and neuronal function,
neuronal circuit alteration, and behavior impairments,
involved in amyotrophic lateral sclerosis (ALS),
frontotemporal lobar degeneration (FTLD), tauopathies, and Alzheimer’s disease.

• 

  Elucidation of pathomechanisms of frontotemporal lobar degeneration (FTLD) spectrum disorders including FTLD, amyotrophic lateral sclerosis (ALS), and other tauopathies.

• 

  Investigation of molecular function of FUS and tau using animal models.

• 

  Development of novel biomarkers focusing on higher brain dysfunction observed in FTLD.

• 

  Development of oligonucleotide therapeutics based on the molecular functions of FUS and tau.

• 

  Development of next-generation imaging diagnostic methods for Alzheimer's disease.

• 

  Development of diagnostics and therapeutics for Alzheimer's disease.

View Research

Members

Introducing the members of the Department of Neurodiagnostics and Therapeutics.

View More

Publications

This section introduces major research achievements such as academic papers published so far.

View More

Tweets by IshigakiLab